“The Food and Drug Administration is breaking down silos, spearheading new data sharing efforts and upskilling its workforce under its data strategy to turn data into a “strategic asset” and drive new efficiencies.”
“We need to address gaps in our data capabilities. We need to break the silos. We need to scale capabilities where there’s an opportunity to build economies of scale. We need to streamline operations. Then we need to coordinate emerging practices such as [artificial intelligence, machine learning] and blockchain,” said FDA Chief Data Officer Ram Iyer during AFCEA Bethesda’s webinar Tuesday. “Our goal is to act as a connective tissue and as an orchestrator…”
“From FDA’s structure and processes, data sharing was slower than it needed to be to respond to public health needs. To solve this challenge, FDA honed in on data management and modernization to drive new business value.”
“FDA’s data strategy revolves around three pillars: driver projects, consistent and repeatable data practices, and fostering a talent network both within the agency and with external partners. These components will create new value, find gaps and drive talent…” Read the full article here.
Source: FDA Tackles Training, Recruiting in Next Phase of Data Strategy – By Sarah Sybert, June 17, 2021. GovernmentCIO.
